17 results
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
have against Wainwright with respect to any conflict of interest that may arise from the fact that the views expressed by its research analysts
6-K
EX-10.1
2z14o lcu0scza8
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-99.1
38txqqlryk3kqhn34
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
8ewtm6un8bo
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
20-F
7qyik87e
31 Mar 15
Annual report (foreign)
12:00am
424B4
t9ttrej
31 Jul 14
Prospectus supplement with pricing info
12:00am
F-1/A
d6p8q
8 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next